2024-09-08 - Analysis Report
## LLY Stock Analysis Report

**Company:** Eli Lilly and Company, a global pharmaceutical company that develops and manufactures medicines for human and animal health.

**Performance Summary:**

**1. Historical Performance:**

* **Cumulative Return:** 528.7%
* **S&P 500 (VOO) Cumulative Return:** 81.34%
* **Outperformance:** 447.36%
* **Relative Outperformance:** 93.09% (This means that LLY's outperformance is currently at the 93.09th percentile of its historical outperformance range)

**2. Recent Price Action:**

* **Closing Price:** 902.71
* **5-day Moving Average:** 935.66
* **20-day Moving Average:** 933.63
* **60-day Moving Average:** 893.73

The stock is currently trading below its 5-day and 20-day moving averages, suggesting a potential short-term downward trend. However, it is above its 60-day moving average, indicating a possible longer-term uptrend.

**3. Technical Indicators:**

* **RSI:** 42.63 (Below 50, indicating a potentially oversold condition)
* **PPO:** -0.59 (Negative, suggesting a potential downward trend)
* **Delta_Previous_Relative_Divergence:** 6.22 (Positive, indicating a potential short-term upward trend)
* **Expected Return:** 33.33% (This is a maximum 5-year expected return based on current investment)

While the RSI and PPO indicators suggest a potentially bearish outlook, the positive Delta_Previous_Relative_Divergence suggests a possible short-term upward trend.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 3.29 | 11.30 B$ |
| 2024-04-30 | 2.49 | 8.77 B$ |
| 2023-11-02 | -0.06 | 9.50 B$ |
| 2023-08-08 | 1.96 | 8.31 B$ |
| 2024-08-08 | 1.96 | 8.31 B$ |

The company's most recent earnings were 3.29 per share, surpassing analyst expectations. The revenue of 11.30 Billion dollars was also above estimates, demonstrating a strong performance. 

**5. Overall Analysis:**

* LLY has consistently outperformed the S&P 500 over the long term, currently showing a high level of outperformance. 
* Recent price action shows some potential short-term weakness but remains positive on a longer time frame.
* Technical indicators suggest mixed signals, with some suggesting a potential short-term upward trend while others point to a bearish outlook.
* The company's most recent earnings performance exceeded expectations, demonstrating strong growth and profitability.

**Conclusion:**

Overall, LLY remains a strong performer with a history of consistent outperformance and positive growth prospects. The recent price action and technical indicators suggest mixed signals, but the company's strong earnings performance provides a positive outlook. Investors should monitor the stock closely for signs of further growth or potential pullbacks. 
